Trials / Unknown
UnknownNCT03845530
The Inflammatory Burden in Hemodialysis vs. Peritoneal Dialysis Patients: the Role of Alpha-defensin
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Hillel Yaffe Medical Center · Other Government
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to determine the levels of alpha-defensin throughout the hemodialysis course compared to the levels at the end of a course of peritoneal dialysis, as a reflection of the inflammatory burden.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood Test | Blood test taken and sent for laboratory analysis |
Timeline
- Start date
- 2019-03-01
- Primary completion
- 2020-03-01
- Completion
- 2020-03-01
- First posted
- 2019-02-19
- Last updated
- 2019-02-19
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT03845530. Inclusion in this directory is not an endorsement.